It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Nuformix plc (NFX) Ordinary 0.1p Shares

Sell:1.95p Buy:2.10p 0 Change: No change
Market closed Prices as at close on 14 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1.95p
Buy:2.10p
Change: No change
Market closed Prices as at close on 14 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1.95p
Buy:2.10p
Change: No change
Market closed Prices as at close on 14 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and NXP002. Its pre-clinical pipeline includes NXP003. It is developing NXP001 for oncology supportive care. It is developing NXP002 for the treatment of multiple fibrotic diseases. NXP003 targets a mechanism understood to confer resistance to immuno-oncology, chemotherapy and radiotherapy cancer treatments.

Contact details

Address:
153 Science Park, Milton Road
CAMBRIDGE
CB4 0GN
United Kingdom
Telephone:
+44 (01223) 627222
Website:
https://nuformix.com/

Important dates

Future events
There are no future events available.
Past events
General meeting 29 March 2021 29/03/21
Interim results 22 December 2020 22/12/20
AGM 20 August 2020 20/08/20
Annual report 28 July 2020 28/07/20
Final results 22 July 2020 22/07/20

General stock information

EPIC:
NFX
ISIN:
GB00BYW79Y38
Market cap:
£11.98 million
Shares in issue:
591.61 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.